Richard F. Kefford

Genotype-phenotype studies in CDKN2A (p16INK4a/p14ARF) mutation positive and negative Australian high risk melanoma families1

Graham J. Mann, Angelo V. Sklavos, Richard F. Kefford, 2004 .

bcGST - an interactive bias-correction method to identify over-represented gene-sets in boutique arrays

Jean Yee Hwa Yang, Matthew Wongchenko, Yibing Yan, 2017, bioRxiv.

Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition

Dario Strbenac, Richard F. Kefford, Alexander M. Menzies, 2020, Nature Communications.

Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.

Jedd D. Wolchok, Antoni Ribas, Richard F. Kefford, 2016 .

Preexisting MEK1P124 Mutations Diminish Response to BRAF Inhibitors in Metastatic Melanoma Patients

Richard F. Kefford, Richard A. Scolyer, Georgina V. Long, 2014, Clinical Cancer Research.

Acquired resistance to BRAF inhibition can confer cross-resistance to combined BRAF/MEK inhibition.

Richard F. Kefford, Gulietta M. Pupo, G. Pupo, 2012, The Journal of investigative dermatology.

Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/β-Catenin Signaling

Richard F. Kefford, Richard A. Scolyer, Georgina V. Long, 2014, PloS one.